Publications

Select a publication to expand its details and open the full article.

ReviewBrain Sciences · 2025

Current Applications of Single-Cell RNA Sequencing in Glioblastoma: A Scoping Review

Ordóñez-Rubiano, E.; Rincón-Arias, N; Shelton, W.; Salazar, A.; Sierra, M.; Bertani, R.; Gómez-Amarillo, D.; Hakim, F.; Baldoncini, M.; Payán-Gómez, C.; Cómbita, A.; Ordonez-Rubiano, S.; Parra-Medina, R.
TitleCurrent Applications of Single-Cell RNA Sequencing in Glioblastoma: A Scoping Review
AuthorsOrdóñez-Rubiano, E.; Rincón-Arias, N; Shelton, W.; Salazar, A.; Sierra, M.; Bertani, R.; Gómez-Amarillo, D.; Hakim, F.; Baldoncini, M.; Payán-Gómez, C.; Cómbita, A.; Ordonez-Rubiano, S.; Parra-Medina, R.
Year2025
DOI10.3390/brainsci15030309
ReviewFrontiers in Epigenetics and Epigenomics · 2024

SWI/SNF chromatin remodelers in prostate cancer progression

Ordonez-Rubiano, S.; Strohmier, B.; Sood, S.; Dykhuizen, E.
TitleSWI/SNF chromatin remodelers in prostate cancer progression
AuthorsOrdonez-Rubiano, S.; Strohmier, B.; Sood, S.; Dykhuizen, E.
Year2024
DOI10.3389/freae.2023.1337345
ArticleJournal of Medicinal Chemistry · 2023

Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer

Ordonez-Rubiano, S.; Maschinot, C.; Wang, S.; Sood, S.; Strohmier, B.; McQuade, A.; Smith, B.; Dykhuizen, E.
TitleRational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer
AuthorsOrdonez-Rubiano, S.; Maschinot, C.; Wang, S.; Sood, S.; Strohmier, B.; McQuade, A.; Smith, B.; Dykhuizen, E.
Year2023
DOI10.1021/acs.jmedchem.3c00671
ArticleJournal of Medicinal Chemistry · 2022

Selective and Cell-active PBRM1 Bromodomain Inhibitors Discovered Through NMR Fragment Screening

Shishodia, S.; Nuñez, R.; Strohmier, B.; Bursch, K.; Goetz, C.; Olp, M.; Jensen, D.; Kenske, T.; Ordonez-Rubiano, S.; Blau, M.; Roach, M.; Peterson, F.; Volkman, B.; Dykhuizen, E.; Smith, B.
TitleSelective and Cell-active PBRM1 Bromodomain Inhibitors Discovered Through NMR Fragment Screening
AuthorsShishodia, S.; Nuñez, R.; Strohmier, B.; Bursch, K.; Goetz, C.; Olp, M.; Jensen, D.; Kenske, T.; Ordonez-Rubiano, S.; Blau, M.; Roach, M.; Peterson, F.; Volkman, B.; Dykhuizen, E.; Smith, B.
Year2022
DOI10.1021/acs.jmedchem.2c00864
AbstractThe FASEB Journal · 2022

Design and Synthesis of Bi-Aryl Methylated Lactam Derivatives to Inhibit the BRD7 Bromodomain Function in Prostate Cancer

Ordonez-Rubiano, S.; Maschinot, C.; Dykhuizen, E.
TitleDesign and Synthesis of Bi-Aryl Methylated Lactam Derivatives to Inhibit the BRD7 Bromodomain Function in Prostate Cancer
AuthorsOrdonez-Rubiano, S.; Maschinot, C.; Dykhuizen, E.
Year2022
DOI10.1096/fasebj.2022.36.S1.R2058
ReviewNAR Cancer · 2021

Polycomb Group Proteins in Cancer: Multifaceted Functions and Strategies for Modulation

Wang, S.; Ordonez-Rubiano, S.; Dhiman, A.; Jiao, G.; Strohmier, B.; Krusemark, C.; Dykhuizen, E.
TitlePolycomb Group Proteins in Cancer: Multifaceted Functions and Strategies for Modulation
AuthorsWang, S.; Ordonez-Rubiano, S.; Dhiman, A.; Jiao, G.; Strohmier, B.; Krusemark, C.; Dykhuizen, E.
Year2021
DOI10.1093/narcan/zcab039
ArticleChemBioChem · 2021

A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation

Wang, S.; Alpsoy, A.; Sood, S.; Ordonez-Rubiano, S.; Dhiman, A.; Sun, Y.; Jiao, G.; Krusemark, C.; Dykhuizen, E.
TitleA Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation
AuthorsWang, S.; Alpsoy, A.; Sood, S.; Ordonez-Rubiano, S.; Dhiman, A.; Sun, Y.; Jiao, G.; Krusemark, C.; Dykhuizen, E.
Year2021
DOI10.1002/cbic.202100118
AbstractRevista Colombiana de Ciencias Químico-Farmacéuticas · 2017

Design and Synthesis of Isatinic and Spiro Compounds as Potential Anticancer Agents

Ordonez-Rubiano, S.; Orozco, F.
TitleDesign and Synthesis of Isatinic and Spiro Compounds as Potential Anticancer Agents
AuthorsOrdonez-Rubiano, S.; Orozco, F.
Year2017
VenueRevista Colombiana de Ciencias Químico-Farmacéuticas